WHO greants Sinopharm emergency approval

The World Health Organization (WHO) has granted emergency approval to Chinese manufacturer Sinopharm’s Covid vaccine. „As a new vaccine in the pandemic response arsenal, it has the potential to increase access to vaccines,“ said WHO Vice President Mariângela Simão. The organization now expects the manufacturer to contribute to the Covax joint vaccination campaign. WHO inspectors visited the production facilities and found no shortcomings. They said the evaluation of studies testing the active ingredient showed it to be safe and effective. While Sinopharm’s product has a positive press, doubts surround the effectiveness of Sinovac’s rival product (China.Table reported). WHO approval for this is still pending. fin